Review
doi: 10.1016/j.euf.2018.06.018.
Epub 2018 Jul 11.
Manufacturing and the Market: Rationalizing the Shortage of Bacillus Calmette-Guérin
Affiliations
- PMID: 30005997
- DOI: 10.1016/j.euf.2018.06.018
Item in Clipboard
Review
Manufacturing and the Market: Rationalizing the Shortage of Bacillus Calmette-Guérin
Eur Urol Focus.
2018 Jul.
Abstract
Bacillus Calmette-Guérin (BCG) is used as first-line intravesical therapy following tumor resection of non-muscle-invasive bladder cancer. Primary producers of BCG announced shortages within the last decade, leading to a worldwide shortage. We review the literature examining the BCG shortage and propose solutions to cope with this problem.
Keywords: Bacillus Calmette-Guérin; Bladder cancer; Shortage.
Copyright © 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Association of Bacillus Calmette-Guerin shortages with bladder cancer recurrence: A single-center retrospective study.Urol Oncol. 2020 Nov;38(11):851.e11-851.e17. doi: 10.1016/j.urolonc.2020.07.014. Epub 2020 Aug 13. Urol Oncol. 2020. PMID: 32800440
-
Recurrence Rate and Cost Consequence of the Shortage of Bacillus Calmette-Guérin Connaught Strain for Bladder Cancer Patients.Eur Urol Focus. 2021 Jan;7(1):111-116. doi: 10.1016/j.euf.2019.04.002. Epub 2019 Apr 18. Eur Urol Focus. 2021. PMID: 31005491
-
Utilization of Bacillus Calmette-Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages.Urology. 2019 Feb;124:120-126. doi: 10.1016/j.urology.2018.07.055. Epub 2018 Sep 13. Urology. 2019. PMID: 30219556
-
Building on a Solid Foundation: Enhancing Bacillus Calmette-Guérin Therapy.Eur Urol Focus. 2018 Jul;4(4):485-493. doi: 10.1016/j.euf.2018.10.010. Epub 2018 Nov 8. Eur Urol Focus. 2018. PMID: 30415921 Review.
-
Intravesical bacillus Calmette-Guérin instillation in non-muscle-invasive bladder cancer: A review.Int J Urol. 2018 Jan;25(1):18-24. doi: 10.1111/iju.13410. Epub 2017 Jul 25. Int J Urol. 2018. PMID: 28741703 Review.
Cited by
-
Intravesical Instillation of Azacitidine Suppresses Tumor Formation through TNF-R1 and TRAIL-R2 Signaling in Genotoxic Carcinogen-Induced Bladder Cancer.Cancers (Basel). 2021 Aug 4;13(16):3933. doi: 10.3390/cancers13163933. Cancers (Basel). 2021. PMID: 34439091 Free PMC article.
-
How to Perform Intravesical Chemotherapy after Second TURBT for Non-Muscle-Invasive Bladder Cancer: A Single-Center Experience.J Clin Med. 2022 Dec 26;12(1):169. doi: 10.3390/jcm12010169. J Clin Med. 2022. PMID: 36614970 Free PMC article.
-
A novel, safe, fast and efficient treatment for Her2-positive and negative bladder cancer utilizing an EGF-anthrax toxin chimera.Int J Cancer. 2020 Jan 15;146(2):449-460. doi: 10.1002/ijc.32719. Epub 2019 Nov 1. Int J Cancer. 2020. PMID: 31584195 Free PMC article.
-
COVID-19 Infection and Previous BCG Vaccination Coverage in the Ecuadorian Population.Vaccines (Basel). 2021 Jan 27;9(2):91. doi: 10.3390/vaccines9020091. Vaccines (Basel). 2021. PMID: 33513693 Free PMC article.
-
Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.Front Surg. 2021 Nov 23;8:775527. doi: 10.3389/fsurg.2021.775527. eCollection 2021. Front Surg. 2021. PMID: 34888347 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
